.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cipla
Farmers Insurance
US Department of Justice
Daiichi Sankyo
Fish and Richardson
Medtronic
Boehringer Ingelheim
Colorcon
Express Scripts

Generated: December 15, 2017

DrugPatentWatch Database Preview

Hisun Pharm Hangzhou Company Profile

« Back to Dashboard

What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?

HISUN PHARM HANGZHOU has five approved drugs.



Summary for Hisun Pharm Hangzhou

US Patents:0
Tradenames:5
Ingredients:5
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hisun Pharm HangzhouSIMVASTATINsimvastatinTABLET;ORAL206557-004Nov 13, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouSIMVASTATINsimvastatinTABLET;ORAL206557-002Nov 13, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRBESARTAN AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; irbesartanTABLET;ORAL207896-001Oct 14, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouEPIRUBICIN HYDROCHLORIDEepirubicin hydrochlorideINJECTABLE;INJECTION090075-001Mar 25, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouSIMVASTATINsimvastatinTABLET;ORAL206557-001Nov 13, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRBESARTANirbesartanTABLET;ORAL206194-003Jun 14, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRINOTECAN HYDROCHLORIDEirinotecan hydrochlorideINJECTABLE;INJECTION090016-001Jan 28, 2009APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRBESARTANirbesartanTABLET;ORAL206194-001Jun 14, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRBESARTANirbesartanTABLET;ORAL206194-002Jun 14, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hisun Pharm HangzhouIRBESARTAN AND HYDROCHLOROTHIAZIDEhydrochlorothiazide; irbesartanTABLET;ORAL207896-002Oct 14, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Moodys
Novartis
Covington
UBS
QuintilesIMS
Mallinckrodt
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot